Correlation Between Milestone Pharmaceuticals and Replimune
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Replimune Group, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Replimune.
Diversification Opportunities for Milestone Pharmaceuticals and Replimune
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Milestone and Replimune is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Replimune go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Replimune
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Replimune. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 1.12 times less risky than Replimune. The stock trades about -0.02 of its potential returns per unit of risk. The Replimune Group is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 2,406 in Replimune Group on August 29, 2024 and sell it today you would lose (968.00) from holding Replimune Group or give up 40.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Replimune Group
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Replimune Group |
Milestone Pharmaceuticals and Replimune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Replimune
The main advantage of trading using opposite Milestone Pharmaceuticals and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.The idea behind Milestone Pharmaceuticals and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Replimune vs. Eliem Therapeutics | Replimune vs. Scpharmaceuticals | Replimune vs. Milestone Pharmaceuticals | Replimune vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |